Endoscopic approaches to upper gastrointestinal bleeding

Area of Science:

• Gastroenterology
• Endoscopic interventions
• Gastrointestinal bleeding management

Background:

• Historically, upper gastrointestinal bleeding (UGIB) management relied heavily on surgical interventions.
• Peptic ulcer bleeding with high-risk stigmata of recent hemorrhage (SRH) carried significant risks of rebleeding and mortality.
• Esophageal variceal bleeding also had high mortality rates in previous decades.

Purpose of the Study:

• To evaluate the impact of endoscopic treatment on upper gastrointestinal bleeding outcomes.
• To compare endoscopic therapy with traditional surgical approaches for peptic ulcers and esophageal varices.
• To assess the effectiveness of endoscopic hemostasis in reducing rebleeding and mortality.

Main Methods:

• Review of treatment paradigms for upper gastrointestinal bleeding, focusing on the shift to endoscopy.
• Analysis of outcomes for peptic ulcer bleeding treated with and without endoscopic therapy.
• Assessment of endoscopic hemostasis success rates and rebleeding rates for esophageal varices.

Main Results:

• Endoscopic therapy for peptic ulcers with SRH reduced rebleeding risk from 40-100% to 10-20% and surgical intervention need from up to 35% to 5-10%.
• This led to shorter hospital stays, fewer transfusions, reduced costs, and lower morbidity.
• Mortality for a first esophageal variceal bleed decreased to approximately 20% from 40-60% in prior decades.

Conclusions:

• Endoscopic treatment is the preferred modality for most upper gastrointestinal bleeding, offering substantial patient benefits.
• Recurrent bleeding after initial endoscopic hemostasis may be managed with a second endoscopic attempt.
• Management decisions should consider local expertise, resources, and patient factors, with surgery reserved for failures or massive hemorrhage.